Besides the insight provided by autopsy studies regarding the immune landscape of the pulmonary system in the context of COVID-19, work by Liaoet al.60 demonstrated the role of FCN1+ macrophages in aggravating the severity of pulmonary pathology upon infection by SARS-CoV-2. The gene discussed is FCN1; the disease is COVID-19.